176 related articles for article (PubMed ID: 19365629)
41. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
Bérard A; Sheehy O; Damase-Michel C; Crespin S
Curr Drug Saf; 2012 Jul; 7(3):207-10. PubMed ID: 22950376
[TBL] [Abstract][Full Text] [Related]
42. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
[TBL] [Abstract][Full Text] [Related]
43. Drug prescription in pregnancy: analysis of a large statutory sickness fund population.
Egen-Lappe V; Hasford J
Eur J Clin Pharmacol; 2004 Nov; 60(9):659-66. PubMed ID: 15480609
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensives prescribed for pregnant women in Japan: Prevalence and timing determined from a database of health insurance claims.
Ishikawa T; Obara T; Nishigori H; Miyakoda K; Ishikuro M; Metoki H; Ohkubo T; Sugawara J; Yaegashi N; Akazawa M; Kuriyama S; Mano N
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1325-1334. PubMed ID: 30252182
[TBL] [Abstract][Full Text] [Related]
45. Physician characteristics and prescription drug use during pregnancy: a population-based study.
Weng SS; Chen YH; Lin CC; Keller JJ; Wang IT; Lin HC
Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810
[TBL] [Abstract][Full Text] [Related]
46. [Prescribed and dispensed in the third trimester of pregnancy drugs: What practices and risks?].
Parent G; Mottet N; Mairot P; Baudier F; Carel D; Goguey M; Riethmuller D; Limat S
J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):754-9. PubMed ID: 26481682
[TBL] [Abstract][Full Text] [Related]
47. Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry.
de Jonge L; de Walle HE; de Jong-van den Berg LT; van Langen IM; Bakker MK
Drug Saf; 2015 Aug; 38(8):737-47. PubMed ID: 26041497
[TBL] [Abstract][Full Text] [Related]
48. Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss - An observational study using the EFEMERIS database.
Vabre C; Araujo M; Damase-Michel C; Hurault-Delarue C; Lacroix I
Therapie; 2022; 77(4):405-412. PubMed ID: 34756562
[TBL] [Abstract][Full Text] [Related]
49. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study.
Alema NM; Semagn G; Melesse S; Araya EM; Gebremedhin H; Demsie DG; Asgedom SW; Weldekidan E
BMC Pregnancy Childbirth; 2020 Oct; 20(1):624. PubMed ID: 33059613
[TBL] [Abstract][Full Text] [Related]
50. Annual trends in use of periconceptional folic acid and birth prevalence of major congenital malformations.
Richard-Tremblay AA; Sheehy O; Bérard A
Curr Drug Saf; 2013 Jul; 8(3):153-61. PubMed ID: 23845112
[TBL] [Abstract][Full Text] [Related]
51. Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: impact of fusafungine on rates of prescription of systemic antibiotics.
Fagnani F; German-Fattal M
Am J Respir Med; 2003; 2(6):491-8. PubMed ID: 14719988
[TBL] [Abstract][Full Text] [Related]
52. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
Kulaga S; Zargarzadeh AH; Bérard A
BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
[TBL] [Abstract][Full Text] [Related]
53. Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study.
Rohra DK; Das N; Azam SI; Solangi NA; Memon Z; Shaikh AM; Khan NH
BMC Pregnancy Childbirth; 2008 Jul; 8():24. PubMed ID: 18627607
[TBL] [Abstract][Full Text] [Related]
54. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions.
Souty C; Launay T; Steichen O; Conte C; Turbelin C; Sarazin M; Vilcu AM; Rossignol L; Blanchon T; Lapeyre-Mestre M; Hanslik T
Eur J Clin Pharmacol; 2020 Dec; 76(12):1675-1682. PubMed ID: 32632714
[TBL] [Abstract][Full Text] [Related]
55. Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database.
Hurault-Delarue C; Montastruc JL; Beau AB; Lacroix I; Damase-Michel C
Arch Gynecol Obstet; 2014 Aug; 290(2):263-70. PubMed ID: 24664257
[TBL] [Abstract][Full Text] [Related]
56. Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.
Levy A; Matok I; Gorodischer R; Sherf M; Wiznitzer A; Uziel E; Koren G
J Clin Pharmacol; 2012 Jan; 52(1):78-83. PubMed ID: 21343345
[TBL] [Abstract][Full Text] [Related]
57. French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol.
Gérardin M; Rousselet M; Caillet P; Grall-Bronnec M; Loué P; Jolliet P; Victorri-Vigneau C
BMJ Open; 2019 Jun; 9(6):e027443. PubMed ID: 31256026
[TBL] [Abstract][Full Text] [Related]
58. [[Drug prescription for pregnant women in the department of the Loire] ].
Garcia I; Beyens MN; Gauchoux R; Guy C; Ollagnier M
Therapie; 2000; 55(5):605-11. PubMed ID: 11201975
[TBL] [Abstract][Full Text] [Related]
59. Prescriptions for category D and X drugs during pregnancy in Taiwan: a population-based study.
Kao LT; Chen YH; Lin HC; Chung SD
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1029-34. PubMed ID: 24578346
[TBL] [Abstract][Full Text] [Related]
60. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
